AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 98 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $46,702,000 | +114.4% | 1,237,466 | 0.0% | 0.47% | +97.1% |
| Q2 2016 | $21,779,000 | +44.7% | 1,237,466 | 0.0% | 0.24% | +59.3% |
| Q1 2016 | $15,048,000 | -50.1% | 1,237,466 | 0.0% | 0.15% | -31.2% |
| Q4 2015 | $30,132,000 | +37.3% | 1,237,466 | 0.0% | 0.22% | +105.7% |
| Q3 2015 | $21,953,000 | +0.5% | 1,237,466 | 0.0% | 0.11% | +5.0% |
| Q2 2015 | $21,841,000 | -62.1% | 1,237,466 | -32.7% | 0.10% | -65.3% |
| Q1 2015 | $57,586,000 | -5.5% | 1,837,466 | -12.0% | 0.29% | -21.8% |
| Q4 2014 | $60,933,000 | -13.1% | 2,087,466 | -38.4% | 0.37% | -20.9% |
| Q3 2014 | $70,087,000 | -35.5% | 3,387,466 | -22.8% | 0.47% | -30.7% |
| Q2 2014 | $108,678,000 | +16.9% | 4,387,466 | 0.0% | 0.68% | -31.0% |
| Q1 2014 | $92,970,000 | +18.0% | 4,387,466 | 0.0% | 0.98% | +3.5% |
| Q4 2013 | $78,799,000 | – | 4,387,466 | – | 0.95% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |